Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-11

FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for metoprolol tartrate (Hospira, Inc.), a generic beta-blocker, confirming continued approval of the product under the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL TARTRATE (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL TARTRATE (METOPROLOL TARTRATE)